Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies

v3.21.2
Basis of Presentation and Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2021
Basis of Presentation and Summary of Significant Accounting Policies  
Basis of Presentation and Summary of Significant Accounting Policies

2. Basis of Presentation and Summary of Significant Accounting Policies

These unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and accounting principles generally accepted in the United States (“GAAP”) for interim reporting. Accordingly, certain notes or other information that are normally required by GAAP have been omitted if they substantially duplicate the disclosures contained in the Company’s annual audited consolidated financial statements. Accordingly, the unaudited condensed consolidated financial statements should be read in connection with the Company’s audited financial statements and related notes as of and for the year ended December 31, 2020 (“Annual Report on Form 10-K”). Results of operations reported for interim periods are not necessarily indicative of results for the entire year. In the opinion of management, the Company has made all adjustments necessary to present fairly its condensed consolidated financial statements for the periods presented. Such adjustments are of a normal, recurring nature. The Company’s financial statements have been prepared under the assumption that the Company will continue as a going concern, which contemplates the realization of assets and discharge of liabilities in the normal course of business for the foreseeable future.

The accompanying unaudited condensed consolidated financial statements include the results of the Company and its subsidiaries. The Company’s comprehensive loss is the same as its net loss.

Except for any updates below, no material changes have been made to the Company’s significant accounting policies disclosed in Note 2 of the Notes to the Consolidated Financial Statements in Part II, Item 8 of the Annual Report on Form 10-K.

Retroactive Application of Recapitalization

The Business Combination on December 21, 2020 was accounted for as a recapitalization of equity structure. Pursuant to GAAP, the Company retrospectively recasted the weighted-average shares included within its condensed consolidated statements of operations for the three and six months ended June 30, 2020. Legacy Canoo redeemable convertible preference shares – Angel Series (“Angel Shares”) and Legacy Canoo redeemable convertible preference shares – Seed Series (“Seed Shares”) were converted to Legacy Canoo A series redeemable convertible preference shares and later were exchanged into Legacy Canoo ordinary shares. The basic and diluted weighted-average Legacy Canoo ordinary shares are retroactively converted to shares of the Company’s common stock to conform to the recasted condensed consolidated statements of stockholders' equity (deficit). The following table summarizes the weighted-average common stock of the Company, basic and diluted for the three and six months ended June 30, 2020 after factoring all retroactive application of recapitalization.

12/21/20

    

    

    

    

Weighted

Merger

Recapitalized

Days

Average

As

Conversion

Common

Outstanding

% of

Common

Date

Description

Calculated

Ratio

Stock

in 2020

weighting

Shares

3 months ended 6/30/2020

Weighted-average shares, basic and diluted

8,235,927

1.24

10,207,895

100

%  

10,207,895

12/31/2018

 

Angel Shares

 

51,316,627

 

91

 

100

%  

51,316,627

3/4/2019

 

Seed Shares

 

11,107,496

 

91

 

100

%  

11,107,496

5/6/2019

 

Seed Shares

 

11,107,495

 

91

 

100

%  

11,107,495

 

83,739,513

12/21/20

    

    

    

    

Weighted

As

Merger

Recapitalized

Days

Average

Previously

Conversion

Common

Outstanding

% of

Common

Date

Description

Reported

Ratio

Stock

in 2020

weighting

Shares

6 months ended 6/30/2020

Weighted-average shares, basic and diluted

7,514,282

1.24

9,313,463

100

%  

9,313,463

12/31/2018

 

Angel Shares

 

51,316,627

 

182

 

100

%  

51,316,627

3/4/2019

 

Seed Shares

 

11,107,496

 

182

 

100

%  

11,107,496

5/6/2019

 

Seed Shares

 

11,107,495

 

182

 

100

%  

11,107,495

 

82,845,081

COVID-19

Beginning in the first quarter of 2021 and continuing in the second quarter of 2021, there has been increasing availability and administration of vaccines against COVID-19 in many parts of the world, as well as an easing of restrictions on social, business, travel and government activities and functions. On the other hand, virus variants, infection rates and regulations continue to fluctuate in various regions and there are ongoing global impacts resulting from the pandemic, including challenges and increases in costs for logistics and supply chains and intermittent supplier delays. The Company has also previously been affected by temporary facility closures, employment and compensation adjustments, and impediments to administrative activities supporting its product research and development.

Ultimately, the Company cannot predict the duration or severity of the COVID-19 pandemic or any variant thereof. The Company will continue to monitor macroeconomic conditions to remain flexible and to optimize and evolve its business as appropriate, and the Company will have to project demand and infrastructure requirements globally and deploy its workforce and other resources accordingly.

Fair Value of Financial Instruments

The Company applies the provisions of ASC 820, Fair Value Measurements and Disclosures, which provides a single authoritative definition of fair value, sets out a framework for measuring fair value and expands on required disclosures about fair value measurement. Fair value represents the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company uses the following hierarchy in measuring the fair value of the Company’s assets and liabilities, focusing on the most observable inputs when available:

Level 1  Quoted prices in active markets for identical assets or liabilities.
Level 2  Observable inputs other than Level 1 quoted prices, such as quoted prices for similar assets and liabilities in active markets, quoted prices in markets that are not active for identical or similar assets and liabilities, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3  Valuations are based on inputs that are unobservable and significant to the overall fair value measurement of the assets or liabilities. Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.

Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The following table summarizes the Company’s assets and liabilities that are measured at fair value on a recurring basis as required by ASC 820, by level, within the fair value hierarchy as of June 30, 2021 and December 31, 2020 (in thousands):

June 30, 2021

    

Fair Value

    

Level 1

    

Level 2

    

Level 3

Assets

 

  

 

  

 

  

 

  

Money Market Funds

$

563,565

$

563,565

$

$

Liability

 

  

 

  

 

  

 

  

Contingent earnout shares liability

$

58,101

$

$

$

58,101

December 31, 2020

    

Fair Value

    

Level 1

    

Level 2

    

Level 3

Assets

 

  

 

  

 

  

 

  

Money Market Funds

$

702,422

$

702,422

$

$

Liability

 

 

  

 

  

 

  

Contingent earnout shares liability

$

133,503

$

$

$

133,503

Private placement warrants liability

$

6,613

$

$

6,613

$

As described in Note 10, the Company has a contingent obligation to issue 15.0 million shares of the Company’s common stock to certain stockholders and employees upon the achievement of certain market share price milestones within specified periods following the Business Combination (the “Earnout Shares”). Upon the occurrence of a bankruptcy or liquidation, any unissued Earnout Shares would be fully issued regardless of whether the share price target has been met.

The Earnout Shares are accounted for as a contingent liability and its fair value is determined using Level 3 inputs, since estimating the fair value of this contingent liability requires the use of significant and subjective inputs that may and are likely to change over the duration of the liability with related changes in internal and external market factors. The tranches were valued using the Monte Carlo simulation of the stock prices based on historical and implied market volatility of a peer group of public companies.

Additionally, as described in Note 12, the private placement warrants that were outstanding were converted to public warrants on March 2, 2021. The private placement warrants are accounted for as a liability and its fair value is determined using Level 2 inputs, since the Company’s public warrants are actively traded and the Company’s private placement warrants have terms and provisions that are identical to those of the public warrants.

Following is a summary of the change in fair value of contingent Earnout Shares liability and private placement warrants liability for the six months ended June 30, 2021 (in thousands).

Earnout Shares Liability

Beginning fair value at December 31, 2020

$

133,503

Change in fair value during the period

(75,402)

Ending fair value at June 30, 2021

$

58,101

Private Placement Warrants Liability

Beginning fair value at December 31, 2020

$

6,613

Change in fair value during the period

1,639

Conversion of private placement warrants to public warrants

(8,252)

Ending fair value at June 30, 2021

$